NCT05935644

Brief Summary

The purpose of this research is to test ORCHID (Optimizing Resilience \& Coping with HIV through Internet Delivery), a skills-building intervention that improves mental health status for persons with HIV, who are at-risk for falling out of care.

Trial Health

53
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial recruitment is currently suspended
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
4mo left

Started Oct 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Oct 2024Oct 2026

First Submitted

Initial submission to the registry

June 29, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 7, 2023

Completed
1.2 years until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 27, 2026

Expected
4 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2026

Last Updated

May 22, 2026

Status Verified

May 1, 2026

Enrollment Period

2.1 years

First QC Date

June 29, 2023

Last Update Submit

May 20, 2026

Conditions

Keywords

depressionmobile applicationscortisol levels

Outcome Measures

Primary Outcomes (1)

  • Proportion of Participants who Complete ORCHID

    Average across all participants of the proportion of participants who login to all 8 ORCHID intervention sessions, calculated as total number of sessions opened (0-8) divided by 8.

    Up to 6 months

Secondary Outcomes (2)

  • Depression as measured by Patient Health Questionnaire (PHQ-9)

    Up to 6 months

  • Positive Affect as measured by Positive and Negative Affect Schedule (PANAS)

    Up to 6 months

Study Arms (1)

ORCHID Group

EXPERIMENTAL

Participants in the ORCHID group will receive an online intervention that improves depressive symptoms and positive affect (emotions) for clinic-based persons living with HIV, for up to 6 months.

Behavioral: ORCHID

Interventions

ORCHIDBEHAVIORAL

The intervention includes 8 modules, which are delivered online, approximately 30 minutes per session, and participants will engage a minimum of once per week. Participants may also meet online or in-person with a navigator, up to 4 times.

ORCHID Group

Eligibility Criteria

Age18 Years - 90 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Cis-gender women,
  • Receiving human immunodeficiency virus (HIV) care at the University of Miami Women's HIV Service,
  • Recent history (12-month) of cervical or anal dysplasia or human papilloma virus (HPV) positivity; AND a recent (12-month) history of one or more of the following:
  • i) drug use (alcohol, tobacco products, marijuana, illicit drugs) or ii) depression or iii) psychiatric condition (anxiety, post-traumatic stress disorder (PTSD)) or iv) unsuppressed HIV viral load d. All life stages - pregnant, non-pregnant, pre/post-menopausal

You may not qualify if:

  • Under 18
  • Not able to read/write English at the 6th grade level
  • Cognitively impaired adults (as documented in medical records)
  • Debilitating psychiatric condition (e.g. schizophrenia/bi-polar/psychotic disorders)
  • Prisoners

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Miami School of Medicine

Miami, Florida, 33136, United States

Location

MeSH Terms

Conditions

Acquired Immunodeficiency SyndromePapillomavirus InfectionsDepression

Interventions

Benzethonium

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesDNA Virus InfectionsTumor Virus InfectionsDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Benzylammonium CompoundsQuaternary Ammonium CompoundsAminesOrganic ChemicalsOnium Compounds

Study Officials

  • Lunthita M Duthely, Ed.D.

    University of Miami

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Associate Professor

Study Record Dates

First Submitted

June 29, 2023

First Posted

July 7, 2023

Study Start

October 1, 2024

Primary Completion (Estimated)

October 27, 2026

Study Completion (Estimated)

October 31, 2026

Last Updated

May 22, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations